Monoamine Oxidase MAO
Monoamine oxidases (MAO) are a family of enzymes that catalyze the oxidation of monoamines. They are found bound to the outer membrane of mitochondria in most cell types in the body. They belong to the protein family of flavin-containing amine oxidoreductases. Monoamine oxidases catalyze the oxidative deamination of monoamines. Oxygen is used to remove an amine group from a molecule, resulting in the corresponding aldehyde and ammonia. Monoamine oxidases contain the covalently bound cofactor FAD and are, thus, classified as flavoproteins. Because of the vital role that MAOs play in the inactivation of neurotransmitters, MAO dysfunction is thought to be responsible for a number of psychiatric and neurological disorders. MAO-A inhibitors act as antidepressant and antianxiety agents, whereas MAO-B inhibitors are used alone or in combination to treat Alzheimer’sand Parkinson’s diseases.
www.MedChemExpress.com 1 Monoamine Oxidase Inhibitors & Modulators
(S)-Rasagiline (S)-Rasagiline mesylate (TVP1022; S-PAI) Cat. No.: HY-14200 (TVP1022 (mesylate); S-PAI mesylate) Cat. No.: HY-14200A
Bioactivity: (S)-Rasagiline (TVP1022) is the S-isomer of rasagiline, which Bioactivity: (S)-Rasagiline (TVP1022) mesylate is the S-isomer of is an anti-Parkinson drug, appears to have the same rasagiline, which is an anti-Parkinson drug, appears to have neuroprotective activity as the R-isomer, but is 1000-fold the same neuroprotective activity as the R-isomer, but is less active as an MAO-B inhibitor. 1000-fold less active as an MAO-B inhibitor.
Purity: 99.60% Purity: >98% Clinical Data: No Development Reported Clinical Data: No Development Reported Size: 10mM x 1mL in DMSO, Size: 5 mg, 10 mg, 25 mg 5 mg, 10 mg, 25 mg
2614W94 7-Hydroxy-3,4-dihydro-2(1H)-quinolinone Cat. No.: HY-101578 (3,4-Dihydro-7-hydroxy-2(1H)-quinolinone) Cat. No.: HY-W010130
Bioactivity: 2614W94 is a selective, reversible inhibitor of monoamine Bioactivity: 7-Hydroxy-3,4-dihydro-2(1H)-quinolinone is a weak MAO-A inhibitor, with an IC of 183 μM, and has no effect oxidase-A with a competitive mechanism of inhibition and IC50 50 [1] of 5 nM and Ki of 1.6 nM with serotonin as substrate. on MAO-B .
Purity: >98% Purity: 99.37% Clinical Data: No Development Reported Clinical Data: No Development Reported Size: 1 mg, 5 mg, 10 mg, 20 mg Size: 10mM x 1mL in DMSO, 100 mg
Amitraz Brofaromine (BTS-27419) Cat. No.: HY-B1111 (CGP 11305A) Cat. No.: HY-13339
Bioactivity: Amitraz is a non-systemic acaricide and insecticide, with Bioactivity: Brofaromine (CGP 11305A) is a monoamine oxidase ( MAO) alpha-adrenergic agonist activity, interaction with octopamine inhibitor with IC50 of 0.2μM for MAO-A. receptors of the central nervous system and inhibition of monoamine oxidases and prostaglandin synthesis.
Purity: 98.0% Purity: >98% Clinical Data: No Development Reported Clinical Data: No Development Reported Size: 10mM x 1mL in DMSO, Size: 1 mg, 5 mg, 10 mg, 20 mg 100 mg
Clorgyline hydrochloride CX-157 Cat. No.: HY-14197A Cat. No.: HY-100178
Bioactivity: Clorgyline hydrochloride is an irreversible and selective Bioactivity: CX-157 is a reversible inhibitor of monoamine oxidase-A ( inhibitor of monoamine oxidase A (MAO-A) that is used in MAO-A) with an EC50 of 19.3ng/mL. scientific research; structurally related to Pargyline.
Purity: 99.53% Purity: >98% Clinical Data: No Development Reported Clinical Data: Phase 2 Size: 10mM x 1mL in DMSO, Size: 1 mg, 5 mg, 10 mg 10 mg, 50 mg, 100 mg
Desmethoxyyangonin Eprobemide (Demethoxyyangonin; 5,6-Dehydrokavain) Cat. No.: HY-N0918 (LIS 630) Cat. No.: HY-B1413
Bioactivity: Desmethoxyyangonin is one of the six major kavalactones found Bioactivity: Eprobemide is a non-competitive reversible inhibitor of in the Piper methysticum (kava) plant; reversible inhibitor of monoamine oxidase A. MAO-B.
Purity: 98.0% Purity: 99.63% Clinical Data: No Development Reported Clinical Data: No Development Reported Size: 10mM x 1mL in DMSO, Size: 10mM x 1mL in DMSO, 5 mg, 10 mg 5 mg, 10 mg, 25 mg, 50 mg
2 Tel: 609-228-6898 Fax: 609-228-5909 Email: [email protected]
GSK-LSD1 Dihydrochloride Iproniazid phosphate Cat. No.: HY-100546A Cat. No.: HY-B0886
Bioactivity: GSK-LSD1 Dihydrochloride is a potent, selective and Bioactivity: Iproniazid is a non-selective, irreversible monoamine oxidase irreversible lysine specific demethylase 1 ( LSD1) inhibitor inhibitor (MAOI) of the hydrazine class.
with an IC50 of 16 nM.
Purity: 98.0% Purity: 99.92% Clinical Data: No Development Reported Clinical Data: Launched Size: 10mM x 1mL in DMSO, Size: 10mM x 1mL in Water, 5 mg, 10 mg, 25 mg, 50 mg 100 mg
Isatin Isocarboxazid (Indoline-2,3-dione) Cat. No.: HY-Y0265 Cat. No.: HY-13929
Bioactivity: Isatin (Indoline-2,3-dione) is a potent inhibitor of Bioactivity: Isocarboxazid is a non-selective and irreversible inhibitor of
monoamine oxidase (MAO) with an IC50 of 3 μM. Also binds monoamine oxidase, with an IC50 of 4.8 μM for rat brain [1] to central benzodiazepine receptors (IC 50 against monoamine oxidase in vitro . clonazepam, 123 μM) [1]. Also acts as an antagonist of b… Purity: 97.0% Purity: 98.0% Clinical Data: No Development Reported Clinical Data: Launched Size: 10mM x 1mL in DMSO, Size: 5 mg 100 mg
Lazabemide MAO-B-IN-1 (Ro 19-6327) Cat. No.: HY-14201 Cat. No.: HY-U00343
Bioactivity: Lazabemide(Ro 19-6327) is selective, reversible monoamine Bioactivity: MAO-B-IN-1 is an inhibitor of monoamine oxidase B, used oxidase B (MAO-B) inhibitor (IC50 values are 0.03 and > 100 for the research of neurological diseases. μM for MAO-B and MAO-A respectively).
Purity: 99.71% Purity: >98% Clinical Data: No Development Reported Clinical Data: No Development Reported Size: 10mM x 1mL in DMSO, Size: 1 mg, 5 mg, 10 mg, 20 mg 10 mg, 50 mg
MAO-IN-1 Minaprine Cat. No.: HY-U00015 Cat. No.: HY-B0884
Bioactivity: MAO-IN-1 is a monoamine oxidase B ( MAO B) inhibitor with Bioactivity: Minaprine is a reversible inhibitor of MAO-A; weakly inhibit acetylcholinesterase; an antidepressant for treatment of an IC50 of 20 nM. depression.
Purity: >98% Purity: >98% Clinical Data: No Development Reported Clinical Data: Launched Size: 1 mg, 5 mg, 10 mg, 20 mg Size: 100 mg
Minaprine dihydrochloride Moclobemide Cat. No.: HY-B0884A (Ro111163) Cat. No.: HY-B0534
Bioactivity: Minaprine 2Hcl is a reversible inhibitor of MAO-A; weakly Bioactivity: Moclobemide(Ro111163) is a reversible monoamine oxidase inhibit acetylcholinesterase; an antidepressant for treatment inhibitor (MAOI) selective for isoform A (RIMA) used to treat of depression. major depressive disorder.
Purity: 99.82% Purity: 99.45% Clinical Data: No Development Reported Clinical Data: Launched Size: 10mM x 1mL in DMSO, Size: 10mM x 1mL in DMSO, 100 mg 50 mg, 100 mg
www.MedChemExpress.com 3
Mofegiline hydrochloride Nialamide (MDL72974A) Cat. No.: HY-16677A Cat. No.: HY-B1199
Bioactivity: Mofegiline Hcl (MDL72974A) is a potent and selective Bioactivity: Nialamide is a non-selective, irreversible monoamine oxidase enzyme-activated irreversible inhibitor of MAO-B; shows marked inhibitor (MAOI) of the hydrazine class that was used as an selectivity for the B form (IC50 = 680 and 3.6 nM for MAO-A antidepressant. and MAO-B, respectively.
Purity: 97.19% Purity: 95.0% Clinical Data: No Development Reported Clinical Data: No Development Reported Size: 10mM x 1mL in Water, Size: 10mM x 1mL in DMSO, 5 mg, 10 mg, 50 mg, 100 mg 100 mg
Paeonol Pargyline Cat. No.: HY-N0159 Cat. No.: HY-A0091A
Bioactivity: Paeonol is an active extraction from the root of Paeonia Bioactivity: Pargyline is an irreversible non-selective monoamine oxidase
suffruticosa, Paeonol inhibits MAO-A and MAO-B with IC50 (MAO) inhibitor drug (IC50 for MAO-A is 11.52 nM and for MAO-B of 54.6 μM and 42.5 μM, respectively. is 8.2 nM) .
Purity: 99.98% Purity: >98% Clinical Data: No Development Reported Clinical Data: Launched Size: 10mM x 1mL in DMSO, Size: 500 mg 250 mg, 1 g
Pargyline hydrochloride Phenelzine Cat. No.: HY-A0091 Cat. No.: HY-B1018
Bioactivity: Pargyline hydrochloride is an irreversible inhibitor of Bioactivity: Phenelzine is a non-selective and irreversible monoamine monoamine oxidase (MAO) that is used clinically to treat oxidase inhibitor (MAOI), used as an antidepressant and moderate hypertension. anxiolytic.
Purity: 99.91% Purity: >98% Clinical Data: Launched Clinical Data: Launched Size: 10mM x 1mL in DMSO, Size: 100 mg, 500 mg 500 mg
Phenelzine sulfate Rasagiline Cat. No.: HY-B1018A (AGN1135; TVP1012) Cat. No.: HY-14605A
Bioactivity: Phenelzine sulfate is a non-selective and irreversible Bioactivity: Rasagiline(AGN1135;TVP1012) is a new MAO-B inhibitor for the monoamine oxidase inhibitor (MAOI), used as an antidepressant treatment of idiopathic Parkinson's disease. Target: Monoamine and anxiolytic. Oxidase (MAO)-B Rasagiline (N-propargyl-1-(R)-aminoindan) is a novel, highly potent irreversible monoamine oxidase (MAO)-B inhibitor, anti-Parkinsonian drug. Rasagiline is effective as… Purity: 98.70% Purity: >98% Clinical Data: Launched Clinical Data: Launched Size: 10mM x 1mL in DMSO, Size: 50 mg, 100 mg 100 mg, 500 mg, 1 g, 2 g
Rasagiline 13C3 mesylate racemic Rasagiline mesylate (AGN1135 13C3 racemic; TVP1012 13C3 racemic) Cat. No.: HY-14605BS (AGN1135 (mesylate); TVP1012 (mesylate)) Cat. No.: HY-14605
Bioactivity: Rasagiline 13C3 mesylate racemic is the deuterium labeled Bioactivity: Rasagiline Mesylate is a new MAO-B inhibitor for the treatment Rasagiline, which is an irreversible inhibitor of monoamine of idiopathic Parkinson's disease. Target: Monoamine Oxidase oxidase. (MAO)-B Rasagiline (N-propargyl-1-(R)-aminoindan) is a novel, highly potent irreversible monoamine oxidase (MAO)-B inhibitor, anti-Parkinsonian drug. Rasagiline is effective as… Purity: >98% Purity: 97.56% Clinical Data: No Development Reported Clinical Data: Launched Size: 1 mg, 5 mg, 10 mg Size: 10mM x 1mL in Water, 50 mg, 100 mg
4 Tel: 609-228-6898 Fax: 609-228-5909 Email: [email protected]
Ro 41-1049 hydrochloride Rosmarinic acid Cat. No.: HY-100027A (Labiatenic acid) Cat. No.: HY-N0529
Bioactivity: Ro 41-1049 hydrochloride is a selective, reversible, Bioactivity: Rosmarinic acid (RA) is a widespread phenolic ester compound orally-active MAO-A inhibitor. in the plants. Rosmarinic acid inhibits MAO-A, MAO-B and
COMT enzymes with IC50s of 50.1, 184.6 and 26.7 μM, respectively.
Purity: 99.96% Purity: 99.06% Clinical Data: No Development Reported Clinical Data: Phase 4 Size: 10mM x 1mL in DMSO, Size: 10mM x 1mL in DMSO, 5 mg, 10 mg, 50 mg, 100 mg 50 mg, 100 mg
Rosmarinic acid racemate RS 8359 Cat. No.: HY-N2336 Cat. No.: HY-14260
Bioactivity: Rosmarinic acid racemate is the racemate of Rosmarinic acid. Bioactivity: RS 8359 is a selective and reversible MAO-A inhibitor, with Rosmarinic acid inhibits MAO-A, MAO-B and COMT antidepressant activity.
enzymes with IC50s of 50.1, 184.6 and 26.7 μM, respectively.
Purity: 98.01% Purity: >98% Clinical Data: No Development Reported Clinical Data: No Development Reported Size: 50 mg, 100 mg Size: 1 mg, 5 mg, 10 mg, 20 mg
Safinamide Salsolidine (EMD 1195686; FCE 26743) Cat. No.: HY-70057 (6,7-Dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline) Cat. No.: HY-22385
Bioactivity: Safinamide (EMD 1195686; FCE 26743) selectively and reversibly Bioactivity: Salsolidine is a tetrahydroisoquinoline alkaloid, acts as a inhibits MAO-B with IC50 of 98 nM, exhibits 5918-fold stereoselective competitive MAO A inhibitor. selectivity against MAO-A.
Purity: 99.77% Purity: 95.77% Clinical Data: Launched Clinical Data: No Development Reported Size: 10mM x 1mL in DMSO, Size: 10mM x 1mL in DMSO, 10 mg, 50 mg 25 mg, 50 mg, 100 mg
TB5 Toloxatone Cat. No.: HY-100975 (MD 69276) Cat. No.: HY-14196
Bioactivity: TB5 is a potent, selective and reversible inhibitor of Bioactivity: Toloxatone (MD 69276) is a reversible monoamine oxidase A hMAO-B with a K value of 0.11±0.01 μM. [1] [1] i ( MAOA) inhibitor . Antidepressant .
Purity: 98.0% Purity: 99.34% Clinical Data: No Development Reported Clinical Data: Launched Size: 10mM x 1mL in DMSO, Size: 10mM x 1mL in DMSO, 5 mg, 10 mg, 50 mg, 100 mg 5 mg, 10 mg, 25 mg, 50 mg, 100 mg
Tranylcypromine hemisulfate (dl-Tranylcypromine hemisulfate; Vafidemstat trans-2-Phenylcyclopropylamine hemisulfate salt) Cat. No.: HY-B1496 (ORY-2001) Cat. No.: HY-112623
Bioactivity: Tranylcypromine hemisulfate is an irreversible, nonselective Bioactivity: Vafidemstat (ORY-2001) is a dual lysine-specific histone MAO inhibitor used in the treatment of depression. demethylase ( LSD1)/ MAO-B inhibitor.
Purity: 99.0% Purity: >98% Clinical Data: Launched Clinical Data: No Development Reported Size: 10mM x 1mL in Water, Size: 250 mg, 500 mg 100 mg
www.MedChemExpress.com 5